Business Description
BeyondSpring Inc
NAICS : 325411
SIC : 2833
ISIN : KYG108301006
Total Employee Number:
44Description
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment. Its first asset, Plinabulin is a novel brain-penetrant microtubule modulator with dendritic cell maturation and vasculature modulation mechanism, which has the potential to help mitigate acquired resistance from prior immune checkpoint inhibitors (ICI) treatment in cancer patients. It is a Selective Immunomodulating Microtubule-Binding Agent (SIMBA), which may provide multiple therapeutic opportunities.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 31.96 | |||||
Equity-to-Asset | -1.87 | |||||
Debt-to-Equity | -0.01 | |||||
Debt-to-EBITDA | -0.03 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 38 | |||||
3-Year EPS without NRI Growth Rate | 36.7 | |||||
3-Year FCF Growth Rate | 12.1 | |||||
3-Year Book Growth Rate | -72.3 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 14.64 | |||||
9-Day RSI | 22.91 | |||||
14-Day RSI | 29.86 | |||||
3-1 Month Momentum % | -9.31 | |||||
6-1 Month Momentum % | -5.29 | |||||
12-1 Month Momentum % | -26.15 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.09 | |||||
Quick Ratio | 1.09 | |||||
Cash Ratio | 0.64 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.8 | |||||
Shareholder Yield % | 2.35 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROA % | -26.91 | |||||
ROIC % | -44.3 | |||||
3-Year ROIIC % | 504.35 | |||||
ROC (Joel Greenblatt) % | -236.14 | |||||
ROCE % | -54.4 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 4 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 2.08 | |||||
EV-to-EBIT | -5.55 | |||||
EV-to-EBITDA | -5.67 | |||||
EV-to-Forward-Revenue | 0.97 | |||||
EV-to-FCF | -2.52 | |||||
Earnings Yield (Greenblatt) % | -18.02 | |||||
FCF Yield % | -36.96 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:BYSI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
BeyondSpring Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.18 | ||
| Beta | 0.832 | ||
| 3-Year Sharpe Ratio | 0.44 | ||
| 3-Year Sortino Ratio | 1.22 | ||
| Volatility % | 46.01 | ||
| 14-Day RSI | 29.86 | ||
| 14-Day ATR ($) | 0.130675 | ||
| 20-Day SMA ($) | 1.5605 | ||
| 12-1 Month Momentum % | -26.15 | ||
| 52-Week Range ($) | 1.16 - 2.44 | ||
| Shares Outstanding (Mil) | 41.12 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BeyondSpring Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
BeyondSpring Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-12 | In 114 days | ||
| Second quarter earnings results for 2026 | 2026-08-13 | In 23 days | ||
| First quarter earnings results for 2026 | 2026-05-13 | 1.39 (-6.71%) | ||
| Annual report for 2025 | 2026-03-25 | 1.62 (-3.86%) | ||
| Fourth quarter earnings results for 2025 | 2026-03-25 | 1.62 (-3.86%) | ||
| Third quarter earnings results for 2025 | 2025-11-12 | 2.20 (+11.11%) | ||
| Second quarter earnings results for 2025 | 2025-08-13 | 2.01 (-0.99%) | ||
| First quarter earnings results for 2025 | 2025-05-12 | 1.68 (-4.00%) | ||
| Annual report for 2024 | 2025-03-27 | 1.49 (-9.22%) | ||
| Fourth quarter earnings results for 2024 | 2025-03-27 | 1.49 (-9.22%) |
Show
Entries
BeyondSpring Inc Frequently Asked Questions
What is BeyondSpring Inc(BYSI)'s stock price today?
The current price of BYSI is $1.24. The 52 week high of BYSI is $2.44 and 52 week low is $1.16.
When is next earnings date of BeyondSpring Inc(BYSI)?
The next earnings date of BeyondSpring Inc(BYSI) is 2026-08-13 Est..
Does BeyondSpring Inc(BYSI) pay dividends? If so, how much?
BeyondSpring Inc(BYSI) does not pay dividend.
Guru Commentaries on NAS:BYSI
No articles.
Press Release
Articles on BeyondSpring Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers